RETROSPECTIVE EVALUATION OF THERAPY WITH KETOCONAZOLE IN HORMONE-REFRACTORY PROSTATE CANCER (HRPC)

被引:0
作者
Bonetta, Alberto [1 ]
Derelli, Roberto [1 ]
机构
[1] Ist Ospitaleri Cremona, Cremona, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1942 / 1943
页数:2
相关论文
共 50 条
  • [21] Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC)
    Kattan, Joseph G.
    Farhat, Fady S.
    Chahine, Georges Y.
    Nasr, Fady L.
    Moukadem, Walid T.
    Younes, Fariha C.
    Yazbeck, Nadine J.
    Ghosn, Marwan G.
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (01) : 75 - 79
  • [22] Combination therapy in hormone-refractory prostate cancer
    Daniel P. Petrylak
    Current Oncology Reports, 2001, 3 (5) : 453 - 453
  • [23] Gene profiling in transurethral resection samples of patients with hormone-refractory prostate cancer (HRPC).
    Stoss, O.
    Albers, P.
    Werther, M.
    Zielinsky, D.
    Jost, N.
    Rueschoff, J.
    Henkel, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 251S - 251S
  • [24] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [25] Polyamine-reduced diet in metastatic hormone-refractory prostate cancer (HRPC) patients
    Cipolla, B
    Guillé, F
    Moulinoux, JP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 384 - 387
  • [26] Targeted therapy in hormone-refractory prostate cancer (HPRC)
    Sternberg, C. N.
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
  • [27] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [29] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Oncology, 2005, 2 (11): : 541 - 542
  • [30] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Urology, 2005, 2 (11): : 524 - 525